We are an innovative medicines company with research and development at our core. Our R&D engine powers an industry-leading pipeline focused on delivering transformative medicines to fight disease, restore possibility and help people live life on their own terms.

Researchers in Biomedical Research work across several diseases areas to uncover insights into the origins and pathogenesis of disease to drive drug discovery and early development, while the Development organization leads the advanced clinical development of those medicines, running large clinical trials and steering the way to regulatory approval and access for patients.

This work is powered by technology platforms that help us innovate across our core therapeutic areas: Cardiovascular, Renal and Metabolic, Oncology, Immunology, and Neuroscience. We focus on two established platforms – chemistry and biotherapeutics – as well as three advanced platforms – xRNA, radioligand therapy, and gene and cell therapy – we believe will continue to play an increasingly important role in delivering new medicines for patients.

By building on our strengths, including our long history of scientific innovation and technological leadership, we aim to discover the next generation of medicines that will make a real difference to people’s lives"